California Public Employees Retirement System’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,700
Closed -$712K 2244
2021
Q1
$712K Sell
27,700
-2,500
-8% -$65.7K ﹤0.01% 2735
2020
Q4
$573K Sell
30,200
-600
-2% -$10.3K ﹤0.01% 2835
2020
Q3
$388K Buy
30,800
+3,200
+12% +$40K ﹤0.01% 2921
2020
Q2
$334K Buy
27,600
+14,550
+111% +$155K ﹤0.01% 2960
2020
Q1
$100K Hold
13,050
﹤0.01% 3115
2019
Q4
$232K Buy
+13,050
New +$170K ﹤0.01% 3056
2019
Q3
Sell
-10,153
Closed -$225K 3270
2019
Q2
$225K Buy
+10,153
New +$238K ﹤0.01% 2871

Other funds holding KALV

California Public Employees Retirement System's KALV Position: Q2 2021 in Review

California Public Employees Retirement System sold out of KalVista Pharmaceuticals (KALV) in Q2 2021, closing a stake of 27,700 shares — an estimated $712K sold.

California Public Employees Retirement System first reported a position in KALV in Q2 2019 and held it in 7 quarters. The position peaked at $712K in Q1 2021. 110 funds tracked by Wall St. Rank hold KALV as of Q2 2021.

  • California Public Employees Retirement System reported no remaining KalVista Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 27,700 KalVista Pharmaceuticals shares in Q2 2021, an estimated $712K.
  • California Public Employees Retirement System first reported a position in KalVista Pharmaceuticals in Q2 2019 and held it in 7 quarters.
  • California Public Employees Retirement System's KalVista Pharmaceuticals position peaked at $712K in Q1 2021.
  • 110 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.